Changes of the blood lymphocyte population following /sup 131/I treatment for nodular goiter
Journal Article
·
· Int. J. Radiat. Oncol., Biol. Phys.; (United States)
The blood lymphocyte population was examined in 34 patients who were treated with /sup 131/I for toxic or atoxic nodular goiter. The patients received one to three doses of 300-550 MBq of /sup 131/I administered at 1 week intervals. Lymphocyte counts were significantly reduced both 1 and 6 weeks after treatment. This reduction was accompanied by a changed composition of the lymphocyte population. The frequency of lymphocytes expressing membrane receptors for C'3 (EAC-rosette forming) was significantly reduced 1 and 6 weeks after /sup 131/I-administration. At 6 weeks there was a slight but statistically significant increase of the frequency of T-cells as identified by Leu 1 monoclonal antibodies. This was largely caused by an increased proportion of helper/induced T-cells as identified by Leu 3a monoclonals. /sup 131/I-treatment also reduced the capacity of lymphocytes to secrete immunoglobulins (Ig) upon PWM-stimulation. The most pronounced effect was observed for IgM. Secretion of IgG and IgA were less reduced. Mitogenic stimulations of lymphocytes with PHA and ConA were not significantly changed. We conclude that these changes observed, with the exception of mitogen reactivity, are essentially similar to those occurring after external radiation therapy for cancer. We speculate that blood lymphocytes passing through the continuously irradiated gland are damaged mainly by emitted beta-particles.
- Research Organization:
- Karolinska Hospital, Stockholm, Sweden
- OSTI ID:
- 6590336
- Journal Information:
- Int. J. Radiat. Oncol., Biol. Phys.; (United States), Journal Name: Int. J. Radiat. Oncol., Biol. Phys.; (United States) Vol. 2; ISSN IOBPD
- Country of Publication:
- United States
- Language:
- English
Similar Records
Blood coagulation in patients with toxic goiter
Pathogenesis of nodular goiter and its implications for surgical management
Longitudinal studies of blood lymphocyte capacity in Hodgkin's disease
Journal Article
·
Sun Dec 31 23:00:00 EST 1972
· Probl. Endokrinol., v. 19, no. 5, pp. 22-27
·
OSTI ID:4389567
Pathogenesis of nodular goiter and its implications for surgical management
Journal Article
·
Thu Dec 31 23:00:00 EST 1987
· Surgery; (United States)
·
OSTI ID:5359497
Longitudinal studies of blood lymphocyte capacity in Hodgkin's disease
Journal Article
·
Sat Oct 31 23:00:00 EST 1981
· Cancer (Philadelphia); (United States)
·
OSTI ID:5388713
Related Subjects
550604* -- Medicine-- Unsealed Radionuclides in Therapy-- (1980-)
62 RADIOLOGY AND NUCLEAR MEDICINE
ANIMAL CELLS
ANTIBODIES
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BIOLOGICAL MATERIALS
BLOOD
BLOOD CELLS
BLOOD COUNT
BODY FLUIDS
CONNECTIVE TISSUE CELLS
DAYS LIVING RADIOISOTOPES
DISEASES
ENDOCRINE DISEASES
GLOBULINS
GOITER
HEMIC DISEASES
IMMUNOGLOBULINS
INTERMEDIATE MASS NUCLEI
IODINE 131
IODINE ISOTOPES
ISOTOPES
LEUKOCYTES
LEUKOPENIA
LYMPHOCYTES
LYMPHOPENIA
MATERIALS
MEDICINE
MONOCLONAL ANTIBODIES
NUCLEAR MEDICINE
NUCLEI
ODD-EVEN NUCLEI
ORGANIC COMPOUNDS
PATIENTS
PROTEINS
RADIOISOTOPES
RADIOLOGY
RADIOTHERAPY
SECRETION
SOMATIC CELLS
THERAPY
62 RADIOLOGY AND NUCLEAR MEDICINE
ANIMAL CELLS
ANTIBODIES
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BIOLOGICAL MATERIALS
BLOOD
BLOOD CELLS
BLOOD COUNT
BODY FLUIDS
CONNECTIVE TISSUE CELLS
DAYS LIVING RADIOISOTOPES
DISEASES
ENDOCRINE DISEASES
GLOBULINS
GOITER
HEMIC DISEASES
IMMUNOGLOBULINS
INTERMEDIATE MASS NUCLEI
IODINE 131
IODINE ISOTOPES
ISOTOPES
LEUKOCYTES
LEUKOPENIA
LYMPHOCYTES
LYMPHOPENIA
MATERIALS
MEDICINE
MONOCLONAL ANTIBODIES
NUCLEAR MEDICINE
NUCLEI
ODD-EVEN NUCLEI
ORGANIC COMPOUNDS
PATIENTS
PROTEINS
RADIOISOTOPES
RADIOLOGY
RADIOTHERAPY
SECRETION
SOMATIC CELLS
THERAPY